EZH2 and glioblastoma: Moreover, the palmitoylation of EZH2 mediated by ZDHHC5 facilitates glioma progression, while it also orchestrates the palmitoylation of FAK to augment epithelial-to-mesenchymal transition (EMT) in GBM cells, thereby potentiating their invasive and tumorigenic characteristics (11, 12).